查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726194

计算病理学市场规模、份额、趋势分析报告：按组件、应用、技术、最终用途、地区和细分市场预测，2025 年至 2030 年

Computational Pathology Market Size, Share & Trends Analysis Report By Component By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

计算病理学市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球计算病理学市场规模预计到2030年将达到10.4亿美元，2025年至2030年期间的复合年增长率为8.24%。

这种增长归因于慢性病患病率的上升、对快速诊断的先进解决方案的需求的增加、机器学习 (ML) 和人工智慧 (AI) 技术的日益融合，以及专注于开发先进解决方案的市场参与者对医疗保健的投资不断增加。

将人工智慧 (AI) 和机器学习 (ML) 演算法整合到数位病理工作流程中，可以快速且准确地分析病理影像，从而彻底改变这一领域。人工智慧工具可以帮助病理学家检测模式、预测疾病进展并提供对疾病检测至关重要的临床相关见解。例如，2024 年 9 月，Page 推出了 Page 阿鲁巴 ，这是一款临床多模态、多模式副驾驶，旨在改变个人化医疗和精准肿瘤学。 Alba 从患者数据中提供即时、人工智慧主导的洞察，以前所未有的速度和规模增强临床决策。这项创新标誌着医疗保健领域向通用人工智慧 (AGI) 迈出了一大步，使该行业更接近未来，即人工智慧不仅支持临床医生，而且还与临床医生合作诊断和治疗癌症等复杂疾病。

在这个市场运营的几家公司也专注于开发创新解决方案，以推进计算病理学的应用和性能。例如，2023年8月，微软与佩奇研发中心合作开发了第二代计算病理学基础模型Virchow2和Virchow2G。这些大规模语言模型在大量病理资料上进行训练，以了解临床资讯、病理学观察和疾病结果之间的复杂关係。

Virchow2 和 Virchow2G 可以产生人类可读的文本来回答问题并协助完成报告撰写和案例摘要等任务。这些模型旨在针对特定任务进行微调，并可用于各种计算病理学应用。这项进步代表着利用人工智慧增强病理学家的决策能力和改善计算病理学中的患者照护迈出了重要一步。同样，从传统显微镜到数位病理学的转变也进一步促进了市场的成长。这一转变将提高可及性并促进世界各地病理学家的远端咨询和协作。

随着卫生系统寻求其他开展业务的方式，同时确保遵守安全通讯协定，COVID-19 疫情加速了这一趋势。此外，监管机构对数位病理学的发展做出了重大贡献，促成了各种数位成像系统和软体应用程式的核准。随着组织投资基础设施以支援数位化工作流程，市场预计将在业务效率提高和诊断能力增强的基础上实现显着成长。

计算病理学市场报告重点

  • 从组件来看，软体领域在 2024 年占据了市场主导地位，这要归功于这些解决方案提供的各种优势，有助于增强临床工作流程。
  • 从应用角度来看，由于全球医院和诊断中心对更有效、更准确的诊断工具的需求不断增加，疾病诊断将在应用领域占据主导地位，到 2024 年其收入份额将达到 45.7%。
  • 从技术角度来看，机器学习在 2024 年占据了市场主导地位。这是因为正在开发的计算病理学解决方案越来越多，这些解决方案整合了机器学习技术，以便在医疗机构中提供更好的性能和结果。
  • 按最终用途划分，医院和诊断实验室部门在 2024 年占据最大的市场占有率，为 51.09%。
  • 2024 年，北美占据了最大的市场占有率，为 40.5%。这是由于该地区的医疗保健基础设施正在发展，加上癌症等慢性病发病率上升，以及获得计算病理学解决方案的机会不断增加。
  • 主要企业正在采用各种策略，例如产品发布、合作、收购和合併，以扩大其服务组合併加强其地理影响力，从而导致市场竞争激烈。例如，2023年2月，ClaraPass收购了Crossscope，旨在透过整合组织处理机器人和人工智慧数位病理学来实现「未来实验室」。这种组合透过自动化组织处理提高了工作流程效率，同时利用人工智慧技术进行进阶影像分析和诊断。

目录

第一章调查方法与范围

第二章执行摘要

第三章计算病理学市场变数、趋势和范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
  • 计算病理学市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
    • 新兴科技趋势
    • COVID-19影响分析
    • 使用案例分析

第四章计算病理学市场：各组成部分的估计和趋势分析

  • 2024年及2030年零件市场占有率
  • 细分仪表板
  • 全球计算病理学市场展望（按组成部分）
  • 软体
  • 服务

第五章 计算病理学市场：应用、评估与趋势分析

  • 2024年及2030年的应用市场占有率
  • 细分仪表板
  • 全球计算病理学市场应用展望
  • 疾病诊断
  • 药物研发
  • 学术研究

第六章计算病理学市场：技术评估与趋势分析

  • 2024 年及 2030 年技术市场占有率
  • 细分仪表板
  • 全球计算病理学市场技术展望
  • 机器学习（ML）
    • 深度学习
    • 其他的
  • 自然语言处理 (NLP) 模型
  • 电脑视觉
  • 其他的

第七章计算病理学市场：按最终用途的估计和趋势分析

  • 2024 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 全球计算病理学市场展望（按最终用途）
  • 医院和诊断实验室
  • 生物技术和製药公司
  • 学术研究所
  • 其他的

第 8 章计算病理学市场：区域估计和趋势分析、按组件、按应用、按技术、按最终用途

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 2024年主要企业的市场占有率/地位分析
  • 公司简介
    • Leica Biosystems Nussloch GmbH（Danaher）
    • Hamamatsu Photonics KK
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Mikroscan Technologies, Inc.
    • Epredia（3DHISTECH Ltd.）
    • Visiopharm A/S
    • Proscia Inc.
    • Tempus
    • Huron Technologies International Inc.
    • ContextVision AB
    • CellaVision
    • aetherAI
    • CellCarta
    • IBEX（IBEX MEDICAL ANALYTICS）
    • Nucleai, Inc.
Product Code: GVR-4-68040-548-5

Computational Pathology Market Growth & Trends:

The global computational pathology market size is expected to reach USD 1.04 billion by 2030, registering a CAGR of 8.24% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of chronic diseases, the increasing demand for advanced solutions for faster diagnosis, the rising integration of Machine Learning (ML) and artificial intelligence (AI) technologies and increasing investment in healthcare supported by market players focused on developing advanced solutions.

Integrating artificial intelligence (AI) and machine learning (ML) algorithms into digital pathology workflows is revolutionizing the field, enabling faster and more accurate analysis of pathology images. AI-powered tools can assist pathologists in detecting patterns, predicting disease progression, and giving clinically relevant insights crucial for disease detection. For instance, In September 2024, Paige introduced Paige Alba, a clinical-grade multimodal co-pilot aimed at transforming personalized medicine and precision oncology. Alba provides real-time, AI-driven insights from patient data, enhancing clinical decision-making at unprecedented speed and scale. This innovation represents a major leap toward Artificial General Intelligence (AGI) in healthcare, bringing the industry closer to a future where AI not only supports but collaborates with clinicians in diagnosing and treating complex diseases such as cancer.

Several companies operating in the market also focusing on developing innovative solutions to enhance the application and performance of computational pathology. For instance, in August 2023, Microsoft and Paige researchers developed Virchow2 and Virchow2G, second-generation foundation models for computational pathology. These large language models are trained on vast amounts of pathology data to understand the complex relationships between clinical information, pathology findings, and disease outcomes.

Virchow2 and Virchow2G can generate human-readable text, answer questions, and assist in tasks like report generation and case summarization. The models are designed to be fine-tuned for specific tasks, enabling their use in various computational pathology applications. This advancement represents a significant step forward in leveraging AI to enhance pathologists' decision-making and improve patient care in computational pathology. Similarly, transitioning from traditional microscopy to digital pathology further contributes to the market growth. This shift enhances accessibility and facilitates remote consultations and collaborative efforts among pathologists worldwide.

The COVID-19 pandemic has accelerated this trend as healthcare systems search for alternatives to execute operations while ensuring compliance with safety protocols. Furthermore, regulatory bodies significantly contribute to digital pathology's growth, leading to approvals for various digital imaging systems and software applications. As organizations invest in infrastructure to support digital workflows, the market is expected to witness significant growth driven by enhanced operational efficiencies and improved diagnostic capabilities.

Computational Pathology Market Report Highlights:

  • Based on component, software segment dominated the market in 2024 owing to the various advantages offered by these solutions that help in enhancing clinical workflows.
  • Based on application, disease diagnosis dominated the application segment with a revenue share of 45.7% in 2024 owing to the rising demand for more effective and accurate diagnosis tools in hospitals and diagnostics centers globally.
  • Based on technology, machine learning dominated the market in 2024 owing to the rising development of computational pathology solutions with integrated ML technologies that offer better performance and outcomes in healthcare facilities.
  • Based on end use, hospitals and diagnostic labs segment held the largest market share of 51.09% in 2024, driven by the increasing demand for advanced diagnostic tools and efficient workflow solutions.
  • North America held the largest market share of 40.5% in 2024. This can be attributed to the regions developed healthcare infrastructure and increasing access to the computational pathology solutions coupled with the rising incidents of the chronic diseases such as cancer.
  • Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market. For instance, in February 2023, ClaraPath acquired Crosscope to integrate tissue processing robotics with AI-powered digital pathology, aiming to create the "lab of the future." This combination enhances workflow efficiency by automating tissue processing while leveraging AI technologies for advanced image analysis and diagnostics.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Component
    • 1.1.3. Technology
    • 1.1.4. Application
    • 1.1.5. End Use
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component
    • 2.2.2. Technology
    • 2.2.3. Application
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Computational Pathology Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunity Analysis
  • 3.2. Computational Pathology Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. Emerging Technology Trends
    • 3.2.4. COVID-19 Impact Analysis
    • 3.2.5. Case Study Analysis

Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Computational Pathology Market by Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Computational Pathology Market by Application Outlook
  • 5.4. Disease Diagnosis
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Drug Discovery & Development
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Academic Research
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Computational Pathology Market by Technology Outlook
  • 6.4. Machine Learning (ML)
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Deep Learning
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Natural Language Processing (NLP) Models
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Computer Vision
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Computational Pathology Market by End Use Outlook
  • 7.4. Hospitals and Diagnostic Labs
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Academic and Research Institutes
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, By Component, By Application, By Technology, By End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share/position analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Hamamatsu Photonics K.K.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Koninklijke Philips N.V.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Olympus Corporation
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. F. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Mikroscan Technologies, Inc.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Epredia (3DHISTECH Ltd.)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Visiopharm A/S
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Proscia Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Tempus
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Huron Technologies International Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. ContextVision AB
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. CellaVision
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. aetherAI
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. CellCarta
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives
    • 9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
      • 9.4.16.1. Company overview
      • 9.4.16.2. Financial performance
      • 9.4.16.3. Product benchmarking
      • 9.4.16.4. Strategic initiatives
    • 9.4.17. Nucleai, Inc.
      • 9.4.17.1. Company overview
      • 9.4.17.2. Financial performance
      • 9.4.17.3. Product benchmarking
      • 9.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Computational Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 4 North America Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 5 North America Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 6 North America Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 8 U.S. Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 9 U.S. Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 10 U.S. Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 11 Canada Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 12 Canada Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 13 Canada Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 15 Mexico Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 16 Mexico Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 17 Mexico Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 19 Europe Computational Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 20 Europe Computational Pathology Market, By Component, 2018 - 2030 (USD Million)
  • Table 21 Europe Computational Pathology Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 Europe Computational Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Computational Pathology Market, By End use, 2018 - 2030 (USD Million)
  • Table 24 Germany Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 25 Germany Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 28 UK Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 29 UK Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 30 UK Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 31 UK Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 32 France Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 33 France Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 34 France Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 35 France Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 36 Italy Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 37 Italy Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 38 Italy Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 39 Italy Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 40 Spain Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 41 Spain Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 42 Spain Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 43 Spain Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 45 Denmark Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 46 Denmark Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 47 Denmark Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 48 Sweden Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 49 Sweden Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 50 Sweden Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 51 Sweden Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 52 Norway Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 53 Norway Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 54 Norway Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 55 Norway Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Computational Pathology Market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 61 China Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 62 China Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 63 China Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 64 China Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 65 Japan Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 66 Japan Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 67 Japan Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 68 Japan Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 69 India Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 70 India Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 71 India Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 72 India Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 74 South Korea Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 75 South Korea Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 76 South Korea Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 77 Australia Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 78 Australia Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 79 Australia Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 80 Australia Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 81 Thailand Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 82 Thailand Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 83 Thailand Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 84 Thailand Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 85 Latin America Computational Pathology Market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 87 Latin America Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 88 Latin America Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 89 Latin America Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 90 Brazil Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 91 Brazil Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 92 Brazil Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 93 Brazil Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 95 Argentina Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 96 Argentina Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 97 Argentina Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 98 MEA Computational Pathology Market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 100 MEA Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 101 MEA Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 102 MEA Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 104 South Africa Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 106 South Africa Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 111 UAE Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 112 UAE Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 113 UAE Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 114 UAE Computational Pathology Market By End use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Computational Pathology Market, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Computational Pathology Market By Component, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Computational Pathology Market By Technology, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Computational Pathology Market By Application, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Computational Pathology Market By End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Computational Pathology Market outlook
  • Fig. 9 Computational Pathology competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Computational Pathology Market driver impact
  • Fig. 15 Computational Pathology Market restraint impact
  • Fig. 16 Computational Pathology Market strategic initiatives analysis
  • Fig. 17 Computational Pathology Market: Component movement analysis
  • Fig. 18 Computational Pathology Market: Component outlook and key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030
  • Fig. 20 Services market estimates and forecast, 2018 - 2030
  • Fig. 21 Computational Pathology Market: Application movement analysis
  • Fig. 22 Computational Pathology Market: Application outlook and key takeaways
  • Fig. 23 Disease diagnosis market estimates and forecast, 2018 - 2030
  • Fig. 24 Drug discovery & development market estimates and forecast, 2018 - 2030
  • Fig. 25 Academic research market estimates and forecast, 2018 - 2030
  • Fig. 26 Computational Pathology Market: Technology movement analysis
  • Fig. 27 Computational Pathology Market: Technology outlook and key takeaways
  • Fig. 28 Machine Learning (ML) market estimates and forecast, 2018 - 2030
  • Fig. 29 Deep Learning market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 Natural Language Processing (NLP) models market estimates and forecast, 2018 - 2030
  • Fig. 32 Computer vision market estimates and forecast, 2018 - 2030
  • Fig. 33 Others market estimates and forecast, 2018 - 2030
  • Fig. 34 Computational Pathology Market: End use movement analysis
  • Fig. 35 Computational Pathology Market: End use outlook and key takeaways
  • Fig. 36 Hospitals and Diagnostic Labs market estimates and forecast, 2018 - 2030
  • Fig. 37 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2018 - 2030
  • Fig. 38 Academic and Research Institutes market estimates and forecast, 2018 - 2030
  • Fig. 39 Other market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Computational Pathology Market: Regional movement analysis
  • Fig. 41 Global Computational Pathology Market: Regional outlook and key takeaways
  • Fig. 42 Global Computational Pathology Market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America market estimates and forecasts, 2018 - 2030
  • Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 China market estimates and forecasts, 2018 - 2030
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 72 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 74 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Computational Pathology Market
  • Fig. 77 Key Company Categorization
  • Fig. 78 Company Market Share/Position Analysis, 2024
  • Fig. 79 Strategic Framework